Lutronic Spectra Laser Tattoo Removal

Lutronic spectra xt carbon laser peel or hollywood peel duration.

Lutronic spectra laser tattoo removal.

In addition to the hollywood laser peel no downtime skin brightening treatments spectra offers the best in class tattoo removal with superior color coverage and lutronic continually expands its treatment applications. The spectra xt is called the extended platform because of its widely extended clinical indications and applications as compared to previous similar devices currently on the market. How does lutronic s q switched laser work. Tattoo removal with the lutronic spectra laser in recent years tattoos have become more prevalent and vastly more colorful than ever before.

The q switched laser is the most commonly used for tattoo removal. Our patients are very happy with their results. Spectra mode 3d structure of melanocyte in melasma patient lutronic s advanced dual mode nd yag spectra laser will bring your practice amazing treatment versatility. Simple two tone tattoos have been replaced with professional multi hued tattoos.

Spectra is the first q switched nd yag laser cleared for the treatment of melasma. Veins capillaries. The spectra with its high power output and variety of dye hand pieces from lutronic has become a gold standard for removing tattoos. Spectra xt is the latest new cutting edge device from lutronic corporation.

The lower absorption characteristics of. Intelligently designed with the provider in mind. Treatments for melasma tattoo removal non ablative resurfacing as well as pigmented lesions. Adequate skin cooling maximises patient comfort and allows practitioners to deliver more energy reliably.

When the proper wavelength is applied the ink absorbs the energy preferentially causing it to. Removal of tattoos depends on the principle of selective photothermolysis. Additionally its two dye. Tattoo removal using spectra laser los angeles skin perfect brothers duration.

July 09 2019 globe newswire lutronic vision lutronic or the company a wholly owned subsidiary of lutronic corporation today announced that it will present clinical trial data at the 19theuropean society of retina specialists euretina congress to be held at the palais des congres in paris france from september 5 8 2019.